Clinical Study of autologous blood injection for the treatment of recurrent temporomandibular joint dislocatio
- Conditions
- Recurrent temporomandibular joint (TMJ) dislocation
- Registration Number
- JPRN-UMIN000022197
- Lead Sponsor
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Oral and Maxillofacial Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Not provided
1) Inflammatory diseases of temporomandibular joint, such as rheumatoid arthritis, tuberculous arthritis. 2) Evidence of tumor or tumor like lesion in the TMJ. 3) Temporomandibular disorders caused by metabolic diseases, including crystal deposition diseases such as gout, pseudogout, or crystal arthritis. 4) Intercurrent facial palsy. 5) Serious concomitant systemic disorder, including malignant hypertension, history of severe cardiovascular diseases or cerebrovascular disorders within 6 months, hemorrhagic gastric ulcers, uncontrolled diabetes, apparent bleeding tendency. 6) Under anticoagulant therapy. 7) Suspicion for active infection. 8) History of serious psychiatric illness or psychiatry illness under medical treatment. 9) Others diagnosed as inapplicable cases by an investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method